Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on French STEM Today.
Press releases published on July 24, 2025
Renewal of the Term of the Chairman and Chief Executive Officer of Vallourec
GlobeNewswire
·
July 24, 2025
RENEWAL OF THE TERM OF THE CHAIRMAN AND CHIEF EXECUTIVE OFFICER OF VALLOUREC Meudon (France), on July 24th, 2025 – The Board of Directors of Vallourec unanimously decided today on the recommendation of the Nomination and Governance Committee, to propose …
RENOUVELLEMENT DU PRESIDENT DU CONSEIL D’ADMINISTRATION ET DIRECTEUR GENERAL DE VALLOUREC
GlobeNewswire
·
July 24, 2025
RENOUVELLEMENT DU PRÉSIDENT DU CONSEIL D’ADMINISTRATION ET DIRECTEUR GÉNÉRAL DE VALLOUREC Meudon (France), 24 juillet 2025 – Le Conseil d’administration de Vallourec a décidé à l’unanimité, sur recommandation du Comité des Nominations et de la Gouvernance, …
KLEVV DÉVOILE SA NOUVELLE GAMME DE SSD : LES MODÈLES CRAS C925G, CRAS C910G ET NEO N410+
EIN Presswire
·
July 24, 2025
PERFORMANCES DE NOUVELLE GÉNÉRATION, REFROIDISSEMENT OPTIMAL ET STOCKAGE POLYVALENT POUR LES USAGES LES PLUS EXIGEANTS HONG KONG, July 24, 2025 /EINPresswire.com/ -- KLEVV, la marque grand public de mémoire et de stockage lancée par Essencore, dévoile …
Abivax announces trading resumption of its ordinary shares on Euronext Paris
GlobeNewswire
·
July 24, 2025
Abivax announces trading resumption of its ordinary shares on Euronext Paris PARIS, France, July 24, 2025 – 02:30 p.m. (CEST) – Abivax SA (Euronext Paris: FR0012333284 – ABVX) (“Abivax” or the “Company”), a clinical-stage biotechnology company focused on …
Abivax Announces Pricing of $650M (€554M) Public Offering of American Depositary Shares
GlobeNewswire
·
July 24, 2025
Abivax Announces Pricing of $650M (€554M) Public Offering of American Depositary Shares PARIS, France, July 24, 2025 – 2:30 p.m. (CEST) – Abivax SA (Euronext Paris: FR0012333284 – ABVX) (“Abivax” or the “Company”), a clinical-stage biotechnology company …
Abivax announces temporary trading halt of its ordinary shares on Euronext Paris
GlobeNewswire
·
July 24, 2025
Abivax announces temporary trading halt of its ordinary shares on Euronext Paris PARIS, France, July 24, 2025 – 07:30 a.m. (CEST) – Abivax SA (Euronext Paris: FR0012333284 – ABVX) (“Abivax” or the “Company”), a clinical-stage biotechnology company focused …